West Pharmaceutical
323 hedge funds and large institutions have $6.23B invested in West Pharmaceutical in 2018 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 119 increasing their positions, 105 reducing their positions, and 47 closing their positions.
13% more repeat investments, than reductions
Existing positions increased: 119 | Existing positions reduced: 105
1.38% more ownership
Funds ownership: 94% → 95.39% (+1.4%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
4% less funds holding
Funds holding: 338 → 323 (-15)
9% less capital invested
Capital invested by funds: $6.85B → $6.23B (-$620M)
23% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 47
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UIM
USS Investment Management
London,
United Kingdom
|
+$81.6M |
| 2 |
AllianceBernstein
Nashville,
Tennessee
|
+$57.6M |
| 3 |
WCM Investment Management
Laguna Beach,
California
|
+$53.1M |
| 4 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$37.2M |
| 5 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$28.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
American Century Companies
Kansas City,
Missouri
|
-$66.1M |
| 2 |
GKIM
GW&K Investment Management
Boston,
Massachusetts
|
-$50.4M |
| 3 |
Select Equity Group
New York
|
-$46.5M |
| 4 |
Jennison Associates
New York
|
-$34.9M |
| 5 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$34M |
WST Hedge Fund Activity: Q1 2018 in Review
323 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in West Pharmaceutical (WST) for Q1 2018, worth a combined $6.23B — down 9.1% from $6.85B a quarter earlier.
Sellers outnumbered buyers: 47 funds closed out of WST and 36 opened new positions — a net loss of 11 holders — while 105 trimmed existing stakes and 119 added.
The largest buyer was USS Investment Management, opening a new position worth an estimated $81.6M. The largest seller was American Century Companies, exiting entirely with an estimated $66.1M sold.
- 323 institutional investors held West Pharmaceutical (WST) as of Q1 2018, down from 338 in Q4 2017.
- Funds reported $6.23B of West Pharmaceutical stock for Q1 2018, down 9.1% quarter-over-quarter.
- 36 funds opened new West Pharmaceutical positions in Q1 2018 and 47 closed out, a net change of -11 holders.
- The largest West Pharmaceutical buyer in Q1 2018 was USS Investment Management, an estimated $81.6M added.
- The largest West Pharmaceutical seller in Q1 2018 was American Century Companies, an estimated $66.1M sold.
Based on aggregated 13F filings for Q1 2018.